{"id":2805,"date":"2022-01-04T22:45:43","date_gmt":"2022-01-04T22:45:43","guid":{"rendered":"http:\/\/entrogen.com\/web4\/?p=2805"},"modified":"2022-06-08T22:31:21","modified_gmt":"2022-06-08T22:31:21","slug":"mgmt-webinar-register-now","status":"publish","type":"post","link":"https:\/\/entrogen.com\/web4\/mgmt-webinar-register-now\/","title":{"rendered":"MGMT Webinar"},"content":{"rendered":"

Thank you to everyone who attended our webinar.<\/strong><\/p>\n

If you were unable to attend, we invite you to watch the recording.<\/p>\n

 <\/p>\n

\"Watch<\/a><\/p>\n

 <\/p>\n

 <\/p>\n

\"MGMT<\/a><\/p>\n

 <\/p>\n

PRESENTERS:<\/strong>
\nDr. Rola Saleeb, MD, PhD, FRCPC,
\nPathologist – Unity Health Toronto<\/p>\n

Joeffrey Chahine
\nTechnical Director of Molecular Diagnostics – MedStar Georgetown University Hospital<\/p>\n

 <\/p>\n

In this webinar, Dr. Rola Saleeb of Unity Health Toronto and Joeffrey Chahine of Georgetown University Hospital
\nwill discuss the importance of MGMT methylation analysis in the classification of glioblastomas and how methylation
\nstatus can help predict response to temozolomide treatment. Also gain important insights as they walk you through
\nthe validation process and discuss the pros and cons of various testing methods.<\/p>\n

Learning Objectives:<\/p>\n

\u2022 How to classify weakly methylated glioblastomas
\n\u2022 Clinical relevance of MGMT methylation status and the impact tumor classification has on patient care
\n\u2022 Methods for calculating percent methylation
\n\u2022 Benefits of msPCR versus pyrosequencing and other testing methods
\n\u2022 Useful tips on validating an assay in a clinical setting
\n\u2022 Tools for simplifying data analysis
\n\u2022 Benefits of bringing MGMT methylation testing in-house<\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

January 27, 2022 11am PST | 2pm EST<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2805","post","type-post","status-publish","format-standard","hentry","category-news-events"],"_links":{"self":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/2805","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/comments?post=2805"}],"version-history":[{"count":7,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/2805\/revisions"}],"predecessor-version":[{"id":2899,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/2805\/revisions\/2899"}],"wp:attachment":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/media?parent=2805"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/categories?post=2805"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/tags?post=2805"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}